Fudan University Researcher Provides New Study Findings on Hepatitis (Key points for the management of hepatitis C in the era of pan-genotypic direct-acting antiviral therapy).

A recent study conducted by researchers at Fudan University in Shanghai, China, highlights the global health challenge posed by hepatitis C viral infections. The study emphasizes the importance of improving diagnosis and treatment rates among individuals infected with the hepatitis C virus. The advent of direct-acting antivirals, particularly pan-genotypic regimens like the combination of sofosbuvir and velpatasvir, has shown promising results in achieving a cure for hepatitis C. However, the study also highlights potential obstacles such as drug adverse effects and resistance-associated substitutions, which require careful management and monitoring. [Extracted from the article]